By Amanda Gardner
HealthDay Reporter
TUESDAY, May 15 (HealthDay News) — A two-drug combination that relieves migraines in adults also works well in adolescents, new research indicates.
Although the findings basically support what doctors are already doing, “it is nice to have this officially shown in a study in adolescents,” said Dr. Ellen Drexler, associate director of neurology at Maimonides Medical Center in New York City.
By Serena Gordon
HealthDay Reporter
TUESDAY, April 24 (HealthDay News) — Botox is considered a preventive medication for debilitating migraine headaches, but a new review finds that it may only help people with chronic migraines or chronic daily headaches. And, even then, the effect appears to only be “small to modest.”
The review found that Botox (botulinum toxin A) was no help for people with episodic migraines (fewer than 15 a month) or chronic tension-type headaches.
By Amanda Gardner
HealthDay Reporter
MONDAY, April 23 (HealthDay News) — Dozens of medications are available to prevent debilitating migraine headaches, but most migraine sufferers don’t use them, a new study finds.
“Approximately 40 percent of people with migraines need preventive treatment, and only about one-third of them are actually getting it,” said Dr. Stephen D. Silberstein, co-author of new guidelines developed by the American Academy of Neurology and the American Headache Society.
WEDNESDAY, February 22, 2012 (Health.com) — Middle-aged women are roughly 40% more likely to become depressed if they experience migraine headaches, new research suggests.
What’s more, their risk of depression appears to stay elevated even if the pain stops. Women whose migraines had not troubled them within the past year were just as likely to become depressed as women who were still enduring the sometimes crippling headaches, the study found. Read More
By Madonna Behen
HealthDay Reporter
WEDNESDAY, Feb. 22 (HealthDay News) — As if the debilitating headaches weren’t bad enough, women who get migraines or have had them in the past are at increased risk for depression, a new study suggests.
Migraines are intense, throbbing headaches often accompanied by nausea and sensitivity to light or sound. They are three times more common in women than in men.
By Mary Brophy Marcus
HealthDay Reporter
MONDAY, Feb. 20 (HealthDay News) — Experts are beginning to believe that some non-headache health problems in childhood — such as vomiting and vertigo — might be linked to migraines later in life. Now, a new study suggests a connection between mothers with migraines and colic in infancy.
Colic is a condition marked by excessive crying in an otherwise healthy child.
By Maureen Salamon
HealthDay Reporter
MONDAY, Jan. 9 (HealthDay News) — “Sham” acupuncture worked almost as well on migraine patients as three types of traditional acupuncture, a new study says.
Randomly assigning 480 patients to one of four groups at nine Chinese hospitals — one sham acupuncture group and three receiving accepted types — an international team of researchers, including Dr. Fan-rong Liang at Chengdu University in China, found that between 50 percent and 75 percent of those with migraines felt better after sham or real acupuncture, respectively, after 16 weeks.
WEDNESDAY, Dec. 14 (HealthDay News) –
Headache affects 50 percent of HIV/AIDS patients in the United States, and many of those headaches are severe, a new study says.
About 27.5 percent of the 200 HIV/AIDS patients in the study suffered “chronic migraine,” a rare condition in which a person has migraine symptoms (with or without other headaches) for 15 or more days a month. This condition occurs in only 2 percent of the general population.
WEDNESDAY, Oct. 12 (HealthDay News) — Exercise can prevent migraines just as well as drugs or relaxation techniques, a new study from Sweden suggests.
“Our conclusion is that exercise can act as an alternative to relaxations and [the migraine drug] topiramate when it comes to preventing migraines, and is particularly appropriate for patients who are unwilling or unable to take preventative medicines,” study lead author Emma Varkey, a physiotherapist and doctoral student at the Sahlgrenska Academy, University of Gothenburg, said in a university news release.
FRIDAY, July 8 (HealthDay News) — Behavioral treatments such as relaxation training, hypnosis and biofeedback to help prevent chronic migraine headaches are cost-effective alternatives to prescription drugs, a new study suggests.
Researchers compared the costs of several types of behavioral treatment with preventive prescription drugs. After six months, minimal-contact behavioral treatment was comparable with drug treatment using medicines that cost 50 cents or less per day.
| Text Size: |  |
|
